The influence of vagal afferents on the left ventricular contractile response to intracoronary administration of catecholamines in the conscious dog.
We studied the effect of vagal afferents on the left ventricular contractile response (LVdP/dtmax) to administration of sympathomimetic amines into the left circumflex coronary artery in conscious dogs. The positive inotropic effects of bolus administration of epinephrine, norepinephrine, and isoproterenol were greater during bilateral vagal cold block (BVB) that in the control state with the vagi intact (P less than 0.001). The inotropic potentiation observed with BVB was not due to vagal efferent interruption, since parasympathetic efferent block with atropine did not potentiate the inotropic effects of intracoronary epinephrine (P greater than 0.05). BVB also potentiated the inotropic effects of constant intracoronary infusion of epinephrine (P less than 0.01). BVB alone had no significant effect on LVdP/dtmax; dtmax (P less than 0.05). We propose that the potentiation of the inotropic effects during BVB could result from either interruption of a vagal afferent-mediated negative feedback reflex and/or an unmasking of a sympathetic afferent-mediated positive feedback effect induced by BVB. However, the observations that ganglionic blockade also potentiated the contractile effects of epinephrine supports the concept that a negative feedback reflex does attenuate the inotropic effect of catecholamines in the control state. In conclusion, these data suggest that vagal afferents attenuate the positive inotropic effects of intracoronary administration of catecholamines via a cardiocardiac negative feedback reflex which occurs through a vagal afferent inhibition of sympathetic efferent activity back to the left ventricle.
D000344:Afferent Pathways; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002395:Catecholamines / Q000008:administration & dosage*; D003331:Coronary Vessels; D004285:Dogs; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007545:Isoproterenol / Q000008:administration & dosage; D009200:Myocardial Contraction; D009638:Norepinephrine / Q000008:administration & dosage; D014294:Trimethaphan / Q000494:pharmacology; D014630:Vagus Nerve / Q000503:physiopathology
D002395:Catecholamines; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D014294:Trimethaphan; D001285:Atropine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine